People with Down syndrome helped researchers discover breakthroughs in Alzheimer’s disease almost 40 years ago.
It is now time to bring the latest discoveries in the Alzheimer’s field to those with Down
syndrome.
Introducing
TRC-DS
The Trial-Ready Cohort-Down Syndrome (TRC-DS) is a community of potential clinical trial participants who could help find a cure for Alzheimer’s disease.
As many as nine in 10 people with Down syndrome develop Alzheimer’s disease
There is no cure for Alzheimer’s disease. That’s why participants are needed to support new research into the connection between the two.
TRC-DS needs healthy adults with Down syndrome to advance therapies and potential cures
TRC-DS needs healthy adults between the ages of 25 and 55 with Down syndrome to participate and become part of a larger movement advancing Alzheimer’s disease therapies and potential cures for people with Down syndrome.
Participants are needed
Researchers want to bring the most promising treatments to people with Down syndrome, but participants are needed.
How to Join
This project is funded by the National Institutes of Health’s INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) project, in partnership with:
